• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biocancell Ltd

+ Add to Watchlist

BICL:IT

223.60 ILs 0.30 0.13%

As of 10:24:31 ET on 08/27/2014.

Company Profile for Biocancell Ltd (BICL)

BioCancell Ltd. is a biopharmaceutical company that develops targeted cancer therapy treatments for numerous types of cancer. The treatment is based on utilizing a target gene, such as the H19 gene, an oncofetal gene expressed at high levels in over 40 types of human cancer tissues, while existing at a nearly undetectable level in the surrounding normal tissues.

Contact Information

Biocancell Ltd

8 Hartom St
Jerusalem, 97775
Israel
Phone: 972-2-548-6555
Fax: 972-2-548-6550

Key Executives for Biocancell Ltd (BICL)

Aharon SchwartzChairmanJonathan BurginChief Executive Officer
Avraham HochbergChief Scientist/Co-FounderMonique Ben-AmVP:Clinical Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil